SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Bouamrani A, Ternier J, Ratel D, Benabid AL, Issartel JP, Brambilla E, Berger F. 2006. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem 52: 21032106.
  • Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R. 2008. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 10: R48.
  • Callesen AK, Vach W, Jørgensen PE, Cold S, Tan Q, Depont Christensen R, Mogensen O, Kruse TA, Jensen ON, Madsen JS. 2008. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study. J Proteome Res 7: 14191426.
  • Early Breast Cancer Trialists' Collaborative Group. 1998. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352: 930942.
  • Engwegen JY, Gast MC, Schellens JH, Beijnen JH. 2006. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 27: 251259.
  • Garrisi VM, Abbate I, Quaranta M, Mangia A, Tommasi S, Paradiso A. 2008. SELDI-TOF serum proteomics and breast cancer: which perspective? Expert Rev Proteomics 5: 779785.
  • Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH. 2009a. Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling. Int J Biol Markers 24: 130141.
  • Gast MC, Van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH. 2009b. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS. Oncol Rep 22: 205213.
  • Gast MC, van Tinteren H, Bontenbal M, van Hoesel RQ, Nooij MA, Rodenhuis S, Span PN, Tjan-Heijnen VC, de Vries EG, Harris N, Twisk JW, Schellens JH, Beijnen JH. 2008. Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients. BMC Cancer 8: 389.
  • Gast MC, Schellens JH, Beijnen JH. 2009c. Clinical proteomics in breast cancer: a review. Breast Cancer Res Treat 116: 1729.
  • Gonçalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP, Birnbaum D. 2008. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes. Mol Cell Proteomics 7: 14201433.
  • Gonçalves A, Esterni B, Bertucci F, Sauvan R, Chabannon C, Cubizolles M, Bardou VJ, Houvenaegel G, Jacquemier J, Granjeaud S, Meng XY, Fung ET, Birnbaum D, Maraninchi D, Viens P, Borg JP. 2006. Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 25: 981989.
  • Hutchens TW, Yip TT. 1993. New desorption strategies for the mass spectrometric analysis of macromolecules. Mass Spectrom 7: 576580.
  • Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL, Jr., Drake RR, Semmes OJ. 2003–2004. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers 19: 229238.
  • Mathelin C, Cromer A, Wendling C, Tomasetto C, Rio MC. 2006. Serum biomarkers for detection of breast cancers: a prospective study. Breast Cancer Res Treat 96: 8390.
  • Shin S, Cazares L, Schneider H, Mitchell S, Laronga C, Semmes OJ, Perry RR, Drake RR. 2007. Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg 204: 10651071.
  • Simpson KL, Whetton AD, Dive C. 2009. Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification. J Chromatogr B Anal Technol Biomed Life Sci 877: 12401249.
  • Simpson RJ, Bernhard OK, Greening DW, Moritz RL. 2008. Proteomics-driven cancer biomarker discovery: looking to the future. Curr Opin Chem Biol 12: 7277.
  • Zeidan BA, Cutress RI, Murray N, Coulton GR, Hastie C, Packham G, Townsend PA. 2009. Proteomic analysis of archival breast cancer serum. Cancer Genomics Proteomics 6: 141147.